KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Repligen (RGEN) Cost of Revenue (2016 - 2025)

Repligen (RGEN) has disclosed Cost of Revenue for 16 consecutive years, with $94.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Cost of Revenue fell 26.9% to $94.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $352.0 million, a 2.16% decrease, with the full-year FY2025 number at $352.0 million, down 2.16% from a year prior.
  • Cost of Revenue was $94.1 million for Q4 2025 at Repligen, up from $88.3 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $128.7 million in Q4 2024 to a low of $59.7 million in Q1 2021.
  • A 5-year average of $84.5 million and a median of $82.2 million in 2021 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: soared 90.52% in 2021, then fell 26.9% in 2025.
  • Repligen's Cost of Revenue stood at $82.0 million in 2021, then grew by 10.55% to $90.7 million in 2022, then decreased by 2.83% to $88.1 million in 2023, then surged by 46.03% to $128.7 million in 2024, then dropped by 26.9% to $94.1 million in 2025.
  • Per Business Quant, the three most recent readings for RGEN's Cost of Revenue are $94.1 million (Q4 2025), $88.3 million (Q3 2025), and $91.2 million (Q2 2025).